Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag A clinical trial is testing a new device to reduce chest pain in adults with chronic angina unresponsive to standard treatment.

flag A clinical trial called COSIRA II is enrolling adults with ongoing chronic angina despite maximum medication therapy to test an investigational device aimed at reducing chest pain and improving symptoms. flag About 11 million Americans have angina, often due to reduced heart blood flow, and up to 40% still experience symptoms after standard treatments. flag The study seeks to evaluate the device’s safety and effectiveness, offering potential new options for patients with persistent symptoms. flag Participation is available through specific sites, and more details are available via Shockwave Medical. flag The device is for research use only.

30 Articles